FCN · Insider Trading
FTI Consulting, Inc.
Every open-market purchase and sale reported by FCN officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-12 | Elsy Lisa Boglioli | Director | Sell | −900 | −$135.20K |
| 2026-06-08 | Elsy Lisa Boglioli | Director | F | −138 | −$21.54K |
| 2026-06-08 | Claudio Costamagna | Director | F | −207 | −$32.31K |
| 2026-06-04 | Claudio Costamagna | Director | A | +1,616 | — |
| 2026-06-04 | Nicholas C Fanandakis | Director | A | +1,616 | — |
| 2026-06-04 | Laureen Seeger | Director | A | +1,987 | — |
| 2026-06-04 | Elsy Lisa Boglioli | Director | A | +1,616 | — |
| 2026-06-04 | Stephen C Robinson | Director | A | +1,616 | — |
| 2026-06-04 | Eric T Steigerwalt | Director | A | +1,616 | — |
| 2026-06-04 | Janet Zelenka | Director | A | +1,616 | — |
| 2026-05-14 | Eun Nam | Chief Financial Officer | Buy | +2,000 | +$289.18K |
| 2026-05-14 | Steven Henry Gunby | CEO, Chairman and President | Buy | +10,000 | +$1.44M |
| 2026-05-14 | Paul Alderman Linton | Chief Strategy/Transf. Officer | Buy | +2,400 | +$345.70K |
| 2026-05-07 | Steven Henry Gunby | CEO, Chairman and President | M | +2,477 | +$99.97K |
| 2026-05-05 | Eun Nam | Chief Financial Officer | A | +19,592 | — |
| 2026-03-12 | Paul Alderman Linton | CSTO and Interim CFO | A | +2,333 | — |
| 2026-03-12 | Steven Henry Gunby | CEO, Chairman and President | A | +20,070 | — |
| 2026-03-12 | Curtis P Lu | General Counsel | A | +2,333 | — |
| 2026-03-12 | Brendan J Keating | CAO and Controller | A | +153 | — |
| 2026-03-12 | Ulrike Rabl | Chief Human Resources Officer | A | +1,670 | — |
| 2026-03-12 | Matthew Pachman | VP, Chief Risk/Ethics Officer | A | +153 | — |
| 2026-03-10 | Paul Alderman Linton | CSTO and Interim CFO | F | −371 | −$62.48K |
| 2026-03-10 | Matthew Pachman | VP, Chief Risk/Ethics Officer | F | −20 | −$3.37K |
| 2026-03-10 | Curtis P Lu | General Counsel | MIXED | −328 | −$1.15M |
| 2026-03-10 | Brendan J Keating | CAO and Controller | F | −205 | −$34.52K |
| 2026-03-10 | Ulrike Rabl | Chief Human Resources Officer | F | −10 | −$1.68K |
| 2026-03-10 | Steven Henry Gunby | CEO, Chairman and President | F | −3,248 | −$547.00K |
| 2026-03-09 | Brendan J Keating | CAO and Controller | F | −24 | −$3.97K |
| 2026-03-09 | Matthew Pachman | VP, Chief Risk/Ethics Officer | F | −24 | −$3.97K |
| 2026-03-09 | Curtis P Lu | General Counsel | F | −207 | −$34.26K |
| 2026-03-09 | Ulrike Rabl | Chief Human Resources Officer | F | −167 | −$27.64K |
| 2026-03-09 | Steven Henry Gunby | CEO, Chairman and President | F | −3,458 | −$572.33K |
| 2026-03-09 | Paul Alderman Linton | CSTO and Interim CFO | F | −235 | −$38.89K |
| 2026-02-25 | Curtis P Lu | General Counsel | MIXED | +908 | −$61.74K |
| 2026-02-25 | Paul Alderman Linton | CSTO and Interim CFO | MIXED | +831 | −$73.78K |
| 2026-02-25 | Steven Henry Gunby | CEO, Chairman and President | MIXED | +7,136 | −$791.08K |
| 2025-12-22 | Paul Alderman Linton | CSTO and Interim CFO | A | +5,664 | — |
| 2025-12-22 | Curtis P Lu | General Counsel | A | +11,328 | — |
| 2025-10-27 | Steven Henry Gunby | CEO, Chairman and President | Buy | +7,500 | +$1.13M |
| 2025-09-11 | Paul Alderman Linton | Chief Strategy/Transf. Officer | M | +11,946 | +$410.11K |
| 2025-09-09 | Steven Henry Gunby | CEO, Chairman and President | M | +2,912 | +$99.97K |
| 2025-09-08 | Paul Alderman Linton | Chief Strategy/Transf. Officer | M | +2,912 | +$99.97K |
| 2025-06-10 | Curtis P Lu | General Counsel | MIXED | — | −$615.51K |
| 2025-06-09 | Elsy Lisa Boglioli | Director | F | −138 | −$22.36K |
| 2025-06-09 | Claudio Costamagna | Director | F | −107 | −$17.34K |
| 2025-06-05 | Elsy Lisa Boglioli | Director | A | +1,529 | — |
| 2025-06-05 | Eric T Steigerwalt | Director | A | +1,529 | — |
| 2025-06-05 | Claudio Costamagna | Director | A | +1,529 | — |
| 2025-06-05 | Laureen Seeger | Director | A | +1,880 | — |
| 2025-06-05 | Janet Zelenka | Director | A | +1,529 | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Steven Henry Gunby | CEO, Chairman and President | 323,642 | $44.45M |
| Paul Alderman Linton | Chief Strategy/Transf. Officer | 92,824 | $12.75M |
| Curtis P Lu | General Counsel | 47,288 | $6.49M |
| Claudio Costamagna | Director | 36,529 | $5.02M |
| Mark S. Bartlett | Director | 27,628 | $3.79M |
| Ajay Sabherwal | Chief Financial Officer | 24,777 | $3.40M |
| Holly Paul | Chief Human Resources Officer | 21,614 | $2.97M |
| Eun Nam | Chief Financial Officer | 21,592 | $2.97M |
| Laureen Seeger | Director | 19,265 | $2.65M |
| Nicholas C Fanandakis | Director | 17,753 | $2.44M |
| Brendan J Keating | CAO and Controller | 7,898 | $1.08M |
| Stephen C Robinson | Director | 7,428 | $1.02M |
| Elsy Lisa Boglioli | Director | 4,438 | $609.47K |
| Janet Zelenka | Director | 3,432 | $471.32K |
| Eric T Steigerwalt | Director | 3,432 | $471.32K |
| Ulrike Rabl | Chief Human Resources Officer | 2,471 | $339.34K |
| Matthew Pachman | VP, Chief Risk/Ethics Officer | 1,844 | $253.24K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the FCN quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.